Journal profile · Hematology
Transfusion and Apheresis Science
ISSN 1473-0502 · eISSN 1878-1683 · Elsevier Ltd · ENGLAND · Bimonthly · Founded 2001
Transfusion and Apheresis Science: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.2; hybrid open access; APC about USD 3,160; median 107 days to acceptance (81 articles, last 24 months); community-reported acceptance: easy; 196 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Transfusion and Apheresis Science is published by Elsevier Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Blood transfusion and management, Blood groups and transfusion and Blood donation and transfusion practices, together about 38% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
Official Journal of the World Apheresis Association, Turkish Society of Apheresis, European Society for Haemapheresis and Società Italiana di Emaferesi e Manipolazione CellulareTransfusion and Apheresis Science brings comprehensive and up-to-date information to physicians and health care professionals involved in the rapidly changing fields of transfusion medicine, hemostasis and apheresis. The journal presents original articles relating to scientific and clinical studies in the areas of immunohematology, transfusion practice, bleeding and thrombotic disorders and both therapeutic and donor apheresis including hematopoietic stem cells. Topics covered include the collection and processing of blood, compatibility testing and guidelines for the use of blood products, as well as screening for and transmission of blood-borne diseases. All areas of apheresis - therapeutic and collection - are also addressed. We would like to specifically encourage allied health professionals in this area to submit manuscripts that relate to improved patient and donor care, technical aspects and educational issues.Transfusion and Apheresis Science features a "Theme" section which includes, in each issue, a group of papers designed to review a specific topic of current importance in transfusion and hemostasis for the discussion of topical issues specific to apheresis and focuses on the operators' viewpoint. Another section is "What's Happening" which provides informal reporting of activities in the field. In addition, brief case reports and Letters to the Editor, as well as reviews of meetings and events of general interest, and a listing of recent patents make the journal a complete source of information for practitioners of transfusion, hemostasis and apheresis science. Immediate dissemination of important information is ensured by the commitment of Transfusion and Apheresis Science to rapid publication of both symposia and submitted papers.
From the journal's Aims & Scope
Research area (LetPub): Hematology
Editor-in-chief Gail A. RockPublisher website
Editorial board by country: none in mainland China; most named United States 12, Italy 6, Türkiye 6, France 3, Canada 3 (42 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Blood transfusion and managementMedicine14.5%
- Blood groups and transfusionMedicine11.9%
- Blood donation and transfusion practicesBusiness, Management and Accounting11.7%
- Hematopoietic Stem Cell TransplantationMedicine7.5%
- Hemoglobinopathies and Related DisordersMedicine6%
- Platelet Disorders and TreatmentsMedicine6%
- Trauma, Hemostasis, Coagulopathy, ResuscitationMedicine5.1%
- Complement system in diseasesImmunology and Microbiology5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.2LetPub ·
- Impact factor (publisher)
- 1.2Publisher website ·
- CiteScore 2026-06
- 2.1LetPub ·
- CiteScore (publisher)
- 2.1Publisher website ·
- SJR 2026-06
- 0.41LetPub ·
- SNIP 2026-06
- 0.73LetPub ·
- h-index
- 50LetPub ·
- h-index
- 73OpenAlex ·
- i10-index
- 1,320OpenAlex ·
- 2-year mean citedness
- 0.87OpenAlex ·
- Self-citation rate
- 8.3%LetPub ·
- Share of gold OA articles
- 8.87%LetPub ·
Volume
- Articles per year
- 136LetPub ·
Articles by year OpenAlex count · 4,524 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 193 | 28 | 33 |
| 2025 | 196 | 39 | 168 |
| 2024 | 152 | 64 | 267 |
| 2023 | 177 | 47 | 557 |
| 2022 | 197 | 73 | 850 |
| 2021 | 255 | 86 | 1,757 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
107 daysMedian, submission to acceptance · P25–P75 56 days – 170 days
- Acceptance to online
- median 2 days (81 articles)
- Submission to online
- median 109 days
- Sample
- 81 articles with submission and acceptance dates (368 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 7 daysPublisher website ·
- First decision after review
- 67 daysPublisher website ·
- Submission to acceptance
- 108 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,160 / EUR 2,960 / GBP 2,530 / JPY 391,930 | — | — | |
| Publisher website | USD 3,150 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 1
- Manuscript length
- ≤ 3,000 words
- Reference style
- Numbered, in order of citation
- Highlights
- Optional
- Cover letter
- Required
Article types accepted9, with length limits
- case reportThese should include an abstract; they should not exceed 1,200 words, a maximum of 10 references and an optional 1-2 figures and/or tables.main text ≤ 1,200 words · abstract ≤ 200 words · figures and tables ≤ 2 · references ≤ 10
- case reportsCase Reports These should include an abstract; they should not exceed 1,200 words, a maximum of 10 references and an optional 1-2 figures and/or tables.Length not stated
- full length articleFull Length Article full-length research papers which have not been published previously, except in a preliminary form. An Original paper usually does not excee…Length not stated
- letterContributions which should be concerned with matters of opinion on contributions published in the journal and other matters of interest to researchers in our fi…main text ≤ 1,500 words
- letters-to-the-editorLetters-to-the-Editor Contributions which should be concerned with matters of opinion on contributions published in the journal and other matters of interest to…Length not stated
- original paperously, except in a preliminary form. An Original paper usually does not exceed 3,000 words, longer papers may be considered if relevant, limit of 50 rmain text ≤ 3,000 words
- review articleThese should only be submitted after prior consultation with an Editor. This paper should not exceed 5,000 words but longer papers may be considered if relevant…main text ≤ 5,000 words · references ≤ 100
- review articlesReview Articles These should only be submitted after prior consultation with an Editor. This paper should not exceed 5,000 words but longer papers may be consid…Length not stated
- themed issue contributionsThemed Issue contributions A series of papers focusing on a particular themed topic, managed by Dr Rock, co-Editor in Chief. Themed Issues are often commissione…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Ethical guidelines per Elsevier's Publishing Ethics Policy Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
Open access options available Model summary
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed per Elsevier's article sharing policy Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2001
- ISSN
- 1473-0502
- Electronic ISSN
- 1878-1683
- Society / sponsor
- World Apheresis Association
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Transfusion and Apheresis Science
What CAS zone is Transfusion and Apheresis Science in?
In the 2025 upgraded edition of the CAS Journal Ranking, Transfusion and Apheresis Science is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Transfusion and Apheresis Science?
The latest impact factor listed by LetPub is 1.2; CiteScore 2.1, h-index 73.
How long does peer review take at Transfusion and Apheresis Science?
Based on the dates recorded on 81 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 107 days (interquartile range 56–170 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Transfusion and Apheresis Science?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 1; Manuscript length: ≤ 3,000 words; Reference style: Numbered, in order of citation; Highlights: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Transfusion and Apheresis Science based?
Of the 42 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (12), Italy (6) and Türkiye (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Transfusion and Apheresis Science?
According to LetPub and DOAJ records, Transfusion and Apheresis Science is indexed in SCIE and Scopus.
Is Transfusion and Apheresis Science open access, and what is the APC?
Transfusion and Apheresis Science is a hybrid journal. For open-access publication: APC about USD 3,160.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .